Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images
NCT ID: NCT05627310
Last Updated: 2022-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50000 participants
OBSERVATIONAL
2022-11-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
NCT06831357
Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images
NCT05202626
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
NCT04547673
A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
NCT06829147
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
NCT06129201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training Cohort
Nasopharyngeal endoscopic images collected from 8 hospitals all over China
No interventions assigned to this group
Validation Cohort
Nasopharyngeal endoscopic images collected from 8 hospitals all over China
Diagnostic
Training dataset was used to train the deep learning model, which was validated and tested by external dataset.
Testing Cohort
Nasopharyngeal endoscopic images prospectively collected from 8 hospitals all over China
Diagnostic
Training dataset was used to train the deep learning model, which was validated and tested by external dataset.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic
Training dataset was used to train the deep learning model, which was validated and tested by external dataset.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients were diagnosed with biopsy(NPC, benign hyperplasia). Control corhort(normal nasopharynx) don't require bispsy result.
Exclusion Criteria
* image can not expose most part of lesion clearly.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiangya Hospital of Central South University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
Fujian Medical University Union Hospital
OTHER
Quan Zhou First Affiliated Hospital of Fujian Medical University
UNKNOWN
First Affiliated Hospital of Guangxi Medical University
OTHER
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
The People' s Hospital of Jiangmen
UNKNOWN
Eye & ENT Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongmeng Yu, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Eye&ENT Hospital, Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Quan Zhou First Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian, China
The People' s Hospital of Jiangmen
Jiangmen, Guangdong, China
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
The People' s Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Eye&ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
De-Sheng Wang, MD PhD
Role: primary
Jun Liao, MD PhD
Role: primary
Ming-Zhang Chang, MD
Role: primary
Jie-En Li, MD PhD
Role: primary
Shen-Hong Qu, MD PhD
Role: primary
Wei-Hong Jiang, MD PhD
Role: primary
Jing Ye, MD PhD
Role: primary
Yu-Xuan Shi, MD PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIAD202204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.